Published in Curr Hypertens Rep on June 01, 2003
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) | NCT00000542
Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial. Hypertension (2004) 1.67
Epidemiology of hypertension and cardiovascular disease in African Americans. J Clin Hypertens (Greenwich) (2003) 1.23
Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol (2003) 1.09
Benefits of once-daily therapies in the treatment of hypertension. Vasc Health Risk Manag (2011) 0.89
Influence of albuminuria and glomerular filtration rate on blood pressure response to antihypertensive drug therapy. Vasc Health Risk Manag (2007) 0.88
Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich) (2012) 0.84
Therapy of hypertension in African Americans. Am J Cardiovasc Drugs (2011) 0.84
Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populations. Cardiol Clin (2010) 0.81
PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a). Cardiovasc Drugs Ther (2015) 0.81
Hypertension in special populations. Cardiol Clin (2002) 0.80
Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus. Curr Med Res Opin (2015) 0.79
A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension. Am J Cardiovasc Drugs (2013) 0.77
Initial treatment of hypertension with aliskiren and amlodipine combination gives 6.5 mm Hg greater reduction in systolic BP than does either monotherapy. Evid Based Med (2011) 0.75
Reply: Directly Observed Therapy: A Possible Tool to Tackle Medication Nonadherence in the CVD Epidemic. J Am Coll Cardiol (2017) 0.75
Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient. Curr Hypertens Rep (2015) 0.75